Aripiprazole in Pervasive Developmental Disorder Not Otherwise Specified and Asperger's Disorder: A 14-Week, Prospective, Open-Label Study

OBJECTIVE: The aim of this study was to determine the effectiveness and tolerability of aripiprazole for irritability in pervasive developmental disorder not otherwise specified (PDD-NOS) and Asperger's disorder. METHOD: This is a 14-week, prospective, open-label investigation of aripiprazole i...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Stigler, Kimberly A., Diener, Jonathan T., Kohn, Arlene E., Li, Lang, Erickson, Craig A., Posey, David J., McDougle, Christopher J.
Formato: Artigo
Idioma:Inglês
Publicado em: Mary Ann Liebert, Inc. 2009
Assuntos:
Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2872206/
https://ncbi.nlm.nih.gov/pubmed/19519261
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/cap.2008.093
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados